The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Kanacef M.C. Intramammary Suspension

. Intramammary suspension

Interchem Ireland LtdVPA10555/001/001

Main Information

Trade NameKanacef M.C. Intramammary Suspension
Active SubstancesKanamycin monosulfate
Dosage FormIntramammary suspension
Licence HolderInterchem Ireland Ltd
Licence NumberVPA10555/001/001

Group Information

ATC CodeQJ51RD01 cefalexin, combinations with other antibacterials
Therapeutic ClassAntibacterial


Licence Issued18/04/2008
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back